Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

15 Sept 2012

Abstract excerpt

Cholangiocarcinoma is notoriously difficult to diagnose, and the mortality rate is high due to late clinical presentation. CpG island promoter methylation is frequently seen in cancer development. In the present study, we aimed at identifying novel epigenetic biomarkers with the potential to improve the diagnostic accuracy of cholangiocarcinoma. Microarray data analyses of cholangiocarcinoma cell lines treated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22983262
DOI: 10.4161/epi.22191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel target genes and a valid biomarker panel identified for cholangiocarcinomaPMID 22983262Read ↗

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinomaSemantic proximity Read ↗

Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targetsSemantic proximity Read ↗

Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinomaSemantic proximity Read ↗

Precision medicine in cholangiocarcinomaSemantic proximity Read ↗

Biomarkers for the Management of Cholangiocarcinoma: Unveiling New Horizons for Precision TherapySemantic proximity Read ↗

Establishment of a Novel Nine-gene Signature for the Prognosis of CholangiocarcinomaSemantic proximity Read ↗

DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Genetic and epigenetic changes associated with cholangiocarcinoma: From DNA methylation to microRNAsSemantic proximity Read ↗

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of CholangiocarcinomaSemantic proximity Read ↗

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinomaSemantic proximity Read ↗

Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinomaSemantic proximity Read ↗

Emerging molecular therapeutic targets for cholangiocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.